MET and cancer: To investigate this hypothesis, we generated cancer lines conditionally expressing oncogenic forms of MET effectors KRAS, PI3K, and STAT3 (p20-KRASG12D, p20-PIK3CAE545A, and p20-STAT3A662C_N664C).